Fund overview & performance

Asset class

Based on three-year return


Annualized returns

Between % and %

 


Fund management

Series

Clear all filters

Canada Life International Concentrated Equity Fund

May 31, 2025

The Fund seeks to achieve long-term capital appreciation by investing primarily in equity securities of companies in any country outside of Canada and the United States.

Is this fund right for you?

  • You want your money to grow over a longer term.
  • You want to invest in companies outside of Canada and the U.S.
  • You're comfortable with a medium level of risk.

Risk Rating

Risk Rating: Medium

How is the fund invested? (as of March 31, 2025)

Asset allocation (%)

Name Percent
International Equity 95.6
US Equity 3.8
Cash and Equivalents 0.7
Other -0.1

Geographic allocation (%)

Name Percent
France 16.3
United Kingdom 15.7
Japan 15.0
Germany 14.5
Sweden 8.3
India 5.7
Taiwan 4.3
Switzerland 3.9
United States 3.8
Other 12.5

Sector allocation (%)

Name Percent
Industrial Goods 19.4
Financial Services 15.8
Consumer Goods 15.6
Technology 13.2
Healthcare 11.0
Real Estate 9.5
Basic Materials 5.0
Industrial Services 3.9
Consumer Services 3.5
Other 3.1

Growth of $10,000 (since inception)

Data not available based on date of inception

Fund details (as of March 31, 2025)

Top holdings %
Sap SE 6.3
HDFC Bank Ltd - ADR 5.7
L'Air Liquide SA 5.0
Taiwan Semiconductor Manufactrg Co Ltd - ADR 4.3
Deutsche Boerse AG Cl N 4.3
Sony Group Corp 4.3
AstraZeneca PLC 4.0
Siemens AG Cl N 3.9
Relx PLC 3.9
Nestle SA Cl N 3.9
Total allocation in top holdings 45.6
Portfolio characteristics
Standard deviation 14.0%
Dividend yield 1.9%
Average market cap (million) $236,050.9

Understanding returns

Annual compound returns (%)

1 MO 3 MO YTD 1 YR
{{snapShot.Return1Mth|customNumber:1}}{{snapShot.Return3Mth|customNumber:1}}{{snapShot.ReturnYTD|customNumber:1}}{{snapShot.Return1Yr|customNumber:1}}
3 YR 5 YR 10 YR INCEPTION
{{snapShot.Return3Yr|customNumber:1}}{{snapShot.Return5Yr|customNumber:1}}{{snapShot.Return10Yr|customNumber:1}}{{snapShot.ReturnInception|customNumber:1}}

Calendar year returns (%)

2024 2023 2022 2021
{{snapShot.Return1YrCalendar|customNumber:1}}{{snapShot.Return2YrCalendar|customNumber:1}}{{snapShot.Return3YrCalendar|customNumber:1}}{{snapShot.Return4YrCalendar|customNumber:1}}
2020 2019 2018 2017
{{snapShot.Return5YrCalendar|customNumber:1}}{{snapShot.Return6YrCalendar|customNumber:1}}{{snapShot.Return7YrCalendar|customNumber:1}}{{snapShot.Return8YrCalendar|customNumber:1}}

Range of returns over five years (November 1, 2018 - May 31, 2025)

Best return Best period end date Worst return
Worst period end date
12.5% Aug. 2024 9.6% Dec. 2024
Average return % of periods with positive returns Number of positive periods Number of negative periods
11.3% 100.0% 20 0

Q1 2025 Fund Commentary

Market commentary

Global equities declined in March, in part because of geopolitical unrest and uncertainty. Europe saw a notable development as Germany’s government approved reforms to its constitutional debt brake, a major shift in fiscal policy. Investor optimism rose as the shift could unlock a wave of investments focused on defence, energy security and infrastructure.

Performance

The Fund’s relative exposure to Deutsche Boerse AG had the most positive impact on performance, after the company benefited from its positive fourth-quarter earnings announcement. Relative exposure to Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) and Novo Nordisk AS was negative for performance. Novo Nordisk was negatively affected by disappointing clinical trial results for CagriSema and lower-than-expected demand for its obesity drugs. TSMC’s share price fell because of weakness in information technology stocks and uncertainty about U.S. tariffs.

At the sector level, stock selection in consumer discretionary and materials had the most positive impact on the Fund’s performance. Security selection in health care and industrials had a negative impact on performance.

At a regional level, underweight exposure to Japan had a positive impact on performance. Overweight exposure to Denmark and exposures to Taiwan and Indonesia had a negative effect on performance.

Portfolio activity

There was no significant activity in the Fund during the quarter.

Outlook

The Fund’s holdings are a balanced structure of companies in different parts of the growth spectrum. The sub-advisor is focused on growth companies with good cash flows and strong balance sheets. The sub-advisor believes that these elements are important for long-term investing and in the current uncertain market environment.

C WorldWide Asset Management

Contact information

Toll free: 1-844-730-1633

{{ snapShot.FundName.replace("<em>", "").replace("</em>", "") }}
No matching records found.

Summary

For the period {{NAVPSPerformanceSummary.StartDate}} through {{NAVPSPerformanceSummary.EndDate}} with $10,000 CAD investment

Total returns performance

{{NAVPSPerformanceSummary.Growth | customPercentage}}

Last price

{{NAVPSPerformanceSummary.NAVPS | customCurrency}} CAD

as of market close {{NAVPSPerformanceSummary.NAVPSDate}}

Value of $10,000 investment

{{NAVPSPerformanceSummary.GrowthOfTenThousand | customCurrency}} CAD

Export to: